Funded Tech Companies
Granite Bio
Granite Bio, based in Basel, received equity investments through Novartis Venture Fund, Forbion Capital Partners and Sanofi Ventures.
Company Overview
Company Name
Granite Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Aeschenvorstadt 36
Basel, 4051
CH
Basel, 4051
CH
Phone
Website
Email Address
Company Background Information
Overview
Granite Bio AG is a privately held biotech company founded in 2021 and based in Basel, Switzerland. The company specializes in developing first-in-class therapeutic antibodies targeting the fundamental biology of inflammation, autoimmunity, and fibrosis. Their lead candidates, GRT-001 and GRT-002, are designed to selectively deplete pathogenic cells, offering novel treatment approaches for chronic inflammatory and fibrotic diseases. ?
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/24/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Loustau
Chief Medical Officer
Dominik Hartl
Chief Scientific Officer
Gijs Brink
Company Investors
- Novartis Venture Fund
- Forbion Capital Partners
- Sanofi Ventures
- Versant Ventures
Browse more funded tech companies:
Granify | Granite Source Power
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs